934290-41-2

Upstream product

• 40167-37-1 4-phenyl-1H-pyrrole-3-carbonitrile 
• 38622-91-2 [(p-methylphenyl)sulfonylmethyl]isonitrile 
• 934290-40-1 C₁₉H₁₄N₂O₂ 

Downstream Products

• 1072202-78-8 4-(3-Cyano-4-phenylpyrrole-1-yl)benzamide 

Relevant academic research and scientific papers

NITROGENATED HETEROCYCLIC COMPOUND AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME

The present invention relates to novel compounds having a xanthine oxidase inhibitory effect and an uricosuric effect and pharmaceutical compositions comprising the same as an active ingredient. That is, the present invention relates nitrogen-containing heterocyclic compounds represented by the following general formula (I): wherein Y1 represents N or C(R4) ; Y2 represents N or C(R5) ; R4 and R5 independently represent an alkyl group, a hydrogen atom etc. ; one of R1 and R2 represents an optionally substituted aryl group, an alkoxygroup or an optionally substituted heterocyclic group; the other of R1 and R2 represents a haloalkyl group, a cyanogroup, ahalogenatometc.; and R3 represents a 5-tetrazolyl group or a carboxy group, and pharmaceutically acceptable salts thereof, and pharmaceutical compositions comprising the same as an active ingredient.